Category Stock Exchange

ANI Pharmaceuticals insiders sold 7,934 shares worth $584K,

[ad_1] Substantial holdings remain. Following his sale, Rowland retains ownership of 38,730 shares, while Mutz holds 91,309 shares. The price differential between the two transactions—Rowland’s $74.91 versus Mutz’s $71.64—suggests the sales occurred on different days or through different execution methods,…